TrialThoracic cancer2023

The efficacy and safety of nanoparticle albumin bound-paclitaxel-based regimen as second- or third-line treatment in patients with advanced esophageal squamous cell carcinoma.

Dao Xin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.